序贯免疫猕猴可诱导靶向HIV-1包膜蛋白V3-聚糖位点的异源中和抗体
研究在非人灵长类中采用病毒样颗粒多聚化V3-聚糖免疫原初免、再以递增天然化包膜蛋白-VLP加强的序贯免疫方案,诱导出异源中和抗体并解析抗体/包膜蛋白复合物结构,但加强后出现递增的脱靶抗体;8只免疫猕猴经SHIV攻击后7只感染,唯一未感染动物中和滴度反而最低,提示需更强效的初免-加强方案。
要点
- VLP多聚化V3-聚糖免疫原初免、天然化Env-VLP加强可在猕猴诱导异源中和抗体
- 加强免疫后观察到脱靶抗体递增
- 8只免疫猕猴SHIV攻击后7只感染,唯一未感染动物中和滴度最低
核心结论
- 序贯免疫产生的更强效异源中和对该动物模型的保护是必要的
- 需改进初免-加强方案以提高bNAb效力并激发其他免疫保护机制,对抗HIV-1疫苗研发至关重要
研究设计与样本
- 在非人灵长类(猕猴)中采用V3-聚糖免疫原多聚化于病毒样颗粒(VLP)初免、再以递增天然化Env-VLP加强的序贯免疫方案
- 免疫后8只猕猴接受SHIV攻击
主要发现
- 初免和加强后抗体/Env复合物结构显示靶表位识别并表观成熟以适应聚糖
- 加强免疫后观察到递增的脱靶抗体
- 8只免疫猕猴SHIV攻击后7只感染
- 唯一未感染的猕猴对攻击病毒的中和滴度属于最低之列
局限性
- 需改进初免-加强方案以提高bNAb效力并激发其他免疫保护机制
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Broadly neutralizing antibodies (bNAbs) against HIV-1 develop after prolonged virus and antibody coevolution. Previous studies showed that sequential immunization with a V3-glycan patch germline-targeting HIV-1 envelope trimer (Env) followed by variant Envs can reproduce this process in mice carrying V3-glycan bNAb precursor B cells. However, eliciting bNAbs in animals with polyclonal antibody repertoires is more difficult. We used a V3-glycan immunogen multimerized on virus-like particles (VLPs), followed by boosting with increasingly native-like Env-VLPs, to elicit heterologous neutralizing antibodies in nonhuman primates (NHPs). Structures of antibody/Env complexes after prime and boost vaccinations demonstrated target epitope recognition with apparent maturation to accommodate glycans. However, we also observed increasing off-target antibodies with boosting. Eight vaccinated NHPs were subsequently challenged with simian-human immunodeficiency virus (SHIV), and seven of eight animals became infected. The single NHP that remained uninfected after viral challenge exhibited one of the lowest neutralization titers against the challenge virus. These results demonstrate that more potent heterologous neutralization resulting from sequential immunization is necessary for protection in this animal model. Thus, improved prime-boost regimens to increase bNAb potency and stimulate other immune protection mechanisms are essential for developing anti–HIV-1 vaccines.
引用
- Escolano A, Gristick HB, Gautam R, et al. Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env. Sci Transl Med. 2021. PMID: 34818054. doi:10.1126/scitranslmed.abk1533
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。